Medpage Today on MSN1d
Encouraging DOAC Data for Afib With Various Valvular Heart Diseases
For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...
Investor's Business Daily on MSN2d
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.
Edwards Lifesciences Reports Fourth Quarter Results
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to ...
3D-printed, bioresorbable implant could help patients regenerate their own heart valves
Every year, more than 5 million people in the U.S. are diagnosed with heart valve disease, but this condition has no ...